Skip to content
Menu

Cantor Fitzgerald Reiterates Overweight on MiMedx Group, Maintains $8 Price Target

Benzinga Newsdesk 1 day ago

Analyst RatingsNewsReiterationPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Cantor Fitzgerald analyst Sarah James reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $8 price target.

Cantor Fitzgerald analyst Sarah James reiterates MiMedx Group (NASDAQ:MDXG) with a Overweight and maintains $8 price target.

Read at benzinga.com